Life Sciences Archives - Page 13 of 17 - Becker's Hospital Review

Biogen to spend $7.3B on rare disease drugmaker | CVS Health to cut 5,000 jobs | FDA approves GSK cancer drug | Mich. hospital to close | Pfizer laying off 69 in Ill.

August 2, 2023 BHR Newsletter Virtual Events • Webinars • Whitepapers • OnDemand Learning • Podcasts • MyBHC 1. Biogen to buy rare disease drugmaker for $7.3B Full story 2. Michigan hospital to close Full story 3. CVS Health to cut 5,000 jobs Full story 4. Innovation at breakneck speed is…

Biogen to cut 1,000 jobs | Drug shortages may worsen after tornado hit Pfizer plant | Cancer drug shortages threaten clinical trials | CHS to sell 3 hospitals | 5 Ozempic updates

July 26, 2023 BHR Newsletter Virtual Events • Webinars • Whitepapers • OnDemand Learning • Podcasts • MyBHC 1. Biogen to cut 1,000 jobs Full story 2. CHS to sell 3 hospitals to Tampa General Full story 3. 66 drugs at risk of new, worsened shortages after tornado hit…

Eli Lilly to spend $1.93B on weight loss drugmaker | J&J must pay $19M to cancer patient | Mayo Clinic taps biotech innovation hub leaders | Cost Plus Drugs could hit hospitals by fall | Nurses protest name of Mo. hospital

July 19, 2023 BHR Newsletter Virtual Events • Webinars • Whitepapers • OnDemand Learning • Podcasts • MyBHC 1. Eli Lilly to buy weight loss drugmaker for $1.93B Full story 2. Most socially responsible hospital in each state: Lown Institute Full story 3. Jury rules J&J must pay nearly…

Illumina hit with $476M fine for Grail acquisition | CVS-owned pharma co. to cut 195 workers | Amazon discounts healthcare on Prime Day | Drug trial paused after 7 patient deaths | 138 drugs in shortage

July 12, 2023 BHR Newsletter Virtual Events • Webinars • Whitepapers • OnDemand Learning • Podcasts • MyBHC 1. EU hits Illumina with $476M fine for Grail acquisition Full story 2. Amazon discounts healthcare in Prime Day first Full story 3. Drug trial paused after 7 patient deaths Full story…

Ex-Pfizer worker faces insider training charges | FDA rejects Amneal's Parkinson's drug | Trial for 1st fully AI-generated drug underway | 42 hospitals cutting back care | 1st hemophilia gene therapy approved

July 5, 2023 BHR Newsletter Virtual Events • Webinars • Whitepapers • OnDemand Learning • Podcasts • MyBHC 1. Former Pfizer employee faces insider training charges Full story 2. Florida health system to trim executive ranks through buyouts Full story 3. FDA rejects Amneal's Parkinson's drug Full story 4. Organizations are…

Eli Lilly drug brings 24% weight loss | 7 drugs in shortage | New COVID-19 variant on CDC's radar | Pfizer ends weight loss drug trial | UPMC to help build R&D facility

June 28, 2023 BHR Newsletter Virtual Events • Webinars • Whitepapers • OnDemand Learning • Podcasts • MyBHC 1. Eli Lilly's obesity drug notes 24.2% average weight loss Full story 2. Criticism spreads to US News' hospital rankings Full story 3. 7 drugs now in shortage Full story 4. Innovation at…

Eli Lilly to acquire Dice Therapeutics in $2.4B deal | 5 deaths partially halt drug trial | Kan. hospital fires CEO | Why drug shortages might worsen | Biden taps leader of CDC

June 21, 2023 BHR Newsletter Virtual Events • Webinars • Whitepapers • OnDemand Learning • Podcasts • MyBHC 1. Eli Lilly to acquire Dice Therapeutics for $2.4B Full story 2. Biden announces leader of the CDC Full story 3. 5 deaths partially halt drug trial Full story 4. Innovation at breakneck…

Pfizer running out of penicillin | Illumina CEO resigns | HHS adds 25 drugs to rebate list | Calif. hospital to lay off 100+ | 116 women in health IT to know | Beaconcure raises $14M

June 14, 2023 BHR Newsletter Virtual Events • Webinars • Whitepapers • OnDemand Learning • Podcasts 1. Pfizer to run out of penicillin solutions in next few months Full story 2. California hospital to lay off 'over 100' employees Full story 3. 25 more drugs subject to Inflation…

Merck sues CMS over drug price negotiations | What's in GV's portfolio? | Mark Cuban to sell Humira biosimilar | Pa. system pulls out of US News ranking | Trinity Life Sciences taps new CEO

June 7, 2023 BHR Newsletter Virtual Events • Webinars • Whitepapers • OnDemand Learning • Podcasts 1. Merck sues feds to stop Medicare drug price negotiations Full story 2. 'Misguided methodology': Pennsylvania health system withdraws from US News rankings Full story 3. What's in GV's portfolio? 143 healthcare…

Oncologists ration cancer drugs amid shortage | J&J taps Ceramedix for new resident co. | PTC Therapeutics to lay off 94 | Amazon eyes medical affairs lead | Ascension posts $1.4B operating loss

May 31, 2023 BHR Newsletter Virtual Events • Webinars • Whitepapers • OnDemand Learning • Podcasts 1. Some oncologists are rationing cancer drugs as shortages grow Full story 2. Ascension posts $1.4B Q1 operating loss Full story 3. PTC Therapeutics to lay off 94 Full story 4. The right hybrid…